GO:1903053 regulation of extracellular matrix organization: Regulatory Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903053 (regulation of extracellular matrix organization) is a biological_process term defined as any process that modulates the frequency, rate or extent of extracellular matrix organization.
• The extracellular matrix (ECM) is not inert scaffolding but a dynamic network of collagens, proteoglycans, glycoproteins and associated factors that actively regulates cell behavior.
• ECM organization is controlled at multiple levels, including ciliary machinery, transcription factors such as TFAP2C and Sox9, and cell-collision dynamics.
• Dysregulated ECM organization contributes to cancer progression, vascular aging, fibrosis and developmental defects.
• CRISPR-based knockout, point-mutation, knock-in and overexpression models enable causal testing of ECM-regulatory genes in relevant cell types.
• Studying GO:1903053 requires combining imaging, proteomics, transcriptomics and functional perturbation to capture dynamic ECM remodeling.
Description
The extracellular matrix (ECM) is a complex, tissue-specific assembly of collagens, proteoglycans, glycoproteins and matricellular proteins that provides structural support and biochemical signals to cells. Rather than a static scaffold, the ECM is continuously remodeled, and the regulation of this remodeling is essential for development, tissue homeostasis and repair. The Gene Ontology term GO:1903053, regulation of extracellular matrix organization, captures any process that modulates the frequency, rate or extent of ECM organization. This term is increasingly relevant because ECM dysregulation is a hallmark of cancer, fibrosis, vascular disease and neurodegeneration. Understanding the molecular players that regulate ECM organization can reveal therapeutic targets and biomarkers. Researchers studying GO:1903053 need robust experimental systems to perturb candidate regulators and measure ECM composition, stiffness and anisotropy. This article synthesizes authoritative GO definitions and published literature to provide a research-grade overview of the term, its mechanisms, associated genes and CRISPR-based research methods.
regulation of extracellular matrix organization At A Glance
| GO ID | GO:1903053 |
|---|---|
| GO term | regulation of extracellular matrix organization |
| Ontology | biological_process |
| Synonym | regulation of extracellular matrix organisation; regulation of extracellular matrix organization and biogenesis |
| Major function | Modulates the frequency, rate or extent of extracellular matrix organization |
| Definition source | QuickGO definition: Any process that modulates the frequency, rate or extent of extracellular matrix organization. |
| Related processes | ECM organization, cell adhesion, cell migration, tissue remodeling |
| Disease relevance | Cancer, fibrosis, vascular aging, developmental disorders |
What Is GO:1903053?
GO:1903053, regulation of extracellular matrix organization, is a biological_process term defined as any process that modulates the frequency, rate or extent of extracellular matrix organization. In other words, it encompasses all molecular and cellular activities that control how the ECM is assembled, remodeled, degraded or reorganized, without being the ECM organization process itself. This regulatory term includes signaling events, transcriptional control, post-translational modifications and mechanical feedback that adjust ECM dynamics.
Why Is regulation of extracellular matrix organization Important in Cell Biology?
GO:1903053 is important because the regulation of ECM organization determines tissue architecture, mechanical properties and cell fate decisions. ECM remodeling is not merely a structural event; it influences cell cycle progression, stress responses and differentiation. Dysregulated ECM regulation underlies major human diseases, including cancer, where altered matrix stiffness promotes invasion, and vascular aging, where ECM composition changes drive stiffness. Understanding the regulators of ECM organization can identify therapeutic targets and biomarkers.
• ECM organization controls tissue architecture and mechanical properties.
• Regulation of ECM organization influences cell cycle progression and proliferation.
• ECM remodeling is critical for developmental processes such as larval development.
• Dysregulated ECM organization contributes to cancer progression and metastasis.
• Vascular aging is accelerated by Sox9-dependent changes in ECM composition and stiffness.
• Ciliary machinery regulates ECM organization, linking cilia to matrix dynamics.
• ECM anisotropy is determined by TFAP2C-dependent regulation of cell collisions.
• Neuronal ECM organization is dynamic and can be visualized with HaloTag-HAPLN1.
• ECM regulation modulates stress response genes during development.
• Targeting ECM regulators offers potential for antifibrotic and anticancer therapies.
What Happens During regulation of extracellular matrix organization?
Initiation of ECM remodeling signals
In simple terms: Cells receive signals that tell them to start changing the matrix around them.
Regulation of ECM organization begins when cells receive biochemical or mechanical cues that trigger remodeling. These cues can come from growth factors, integrin signaling, or mechanical forces, and they activate intracellular pathways that control ECM gene expression and secretion. For example, ciliary machinery has been shown to regulate ECM organization, linking sensory organelles to matrix dynamics.
Transcriptional control of ECM components
In simple terms: Specific transcription factors turn ECM genes on or off.
Transcription factors such as TFAP2C and Sox9 directly regulate the expression of ECM components and modifying enzymes. TFAP2C-dependent regulation of cell collisions determines ECM anisotropy, while Sox9 accelerates vascular aging by altering ECM composition and stiffness. These transcriptional programs adjust the balance of collagens, proteoglycans and crosslinking enzymes.
Post-translational modification and assembly
In simple terms: Newly made ECM proteins are chemically modified and assembled outside the cell.
After synthesis, ECM proteins undergo post-translational modifications such as hydroxylation, glycosylation and crosslinking, which are essential for their assembly and function. Regulatory processes at this stage include the activity of modifying enzymes and chaperones that ensure proper folding and secretion.
Dynamic remodeling and feedback
In simple terms: The matrix is constantly rebuilt in response to cell behavior and mechanical forces.
ECM organization is dynamic and subject to feedback regulation. Cell collisions and migration patterns can influence matrix anisotropy through TFAP2C-dependent mechanisms. In neuronal tissues, ECM dynamics can be tracked using HaloTag-HAPLN1, revealing ongoing remodeling. Stress response genes are also regulated by ECM during larval development, indicating feedback between matrix and cellular stress pathways.
Integration with cell cycle and stress responses
In simple terms: The matrix sends signals that affect how cells grow and respond to stress.
Regulation of ECM organization is integrated with cell cycle control and stress responses. A review on cell cycle regulation by ECM highlights how matrix signals influence proliferation. Additionally, ECM regulation of stress response genes during Caenorhabditis elegans larval development demonstrates cross-talk between matrix and stress pathways.
Key Genes Involved in GO:1903053 regulation of extracellular matrix organization
The following genes and proteins are experimentally implicated in the regulation of extracellular matrix organization, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| COL1A1 | Major fibrillar collagen component of ECM | ECM composition and stiffness studies |
| COL1A2 | Major fibrillar collagen component of ECM | ECM assembly and remodeling |
| FN1 | Fibronectin, ECM glycoprotein | Cell adhesion and matrix assembly |
| LAMA1 | Laminin subunit, basement membrane | Basement membrane organization |
| HAPLN1 | Link protein stabilizing ECM | Neuronal ECM dynamics visualized with HaloTag |
| SOX9 | Transcription factor regulating ECM genes | Vascular aging and ECM stiffness |
| TFAP2C | Transcription factor affecting cell collisions | ECM anisotropy determination |
| MMP2 | Matrix metalloproteinase, degrades ECM | ECM remodeling and cancer |
| MMP9 | Matrix metalloproteinase, degrades ECM | ECM remodeling and inflammation |
| TIMP1 | Inhibitor of MMPs | Regulation of ECM degradation |
| TGFB1 | Cytokine inducing ECM synthesis | Fibrosis and ECM regulation |
| CTGF | Matricellular protein promoting ECM | Fibrotic ECM regulation |
| SPARC | Matricellular protein modulating ECM | ECM assembly and cell-matrix interaction |
| ITGB1 | Integrin beta 1, ECM receptor | Cell-ECM adhesion signaling |
| CD44 | Hyaluronan receptor | ECM-mediated cell signaling |
| HAS2 | Hyaluronan synthase | ECM glycosaminoglycan synthesis |
| ADAMTS1 | Protease modifying ECM | ECM turnover and remodeling |
How Is regulation of extracellular matrix organization Regulated?
Regulation of ECM organization is itself controlled by multiple signaling pathways. TGFB1 is a master regulator that induces ECM synthesis and is implicated in fibrosis. Sox9 acts as a transcriptional regulator of ECM composition and stiffness in vascular aging. TFAP2C-dependent regulation of cell collisions determines ECM anisotropy, linking mechanical cell behavior to matrix organization. Ciliary machinery also regulates ECM organization, suggesting that sensory organelles modulate matrix dynamics. Additionally, ECM regulation of stress response genes during larval development indicates feedback between matrix and cellular stress pathways.
regulation of extracellular matrix organization and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SOX9 | Vascular aging, ECM stiffness | Knockout or overexpression in vascular smooth muscle cells |
| TFAP2C | ECM anisotropy, cell collision | Knockout in epithelial cells followed by imaging |
| MMP2 | Cancer invasion and metastasis | Knockout in cancer cell lines |
| MMP9 | Cancer and inflammation | Point mutation to disable catalytic activity |
| HAPLN1 | Neuronal ECM dynamics | Knock-in with HaloTag for live imaging |
Cancer and ECM dysregulation
Altered regulation of ECM organization is a hallmark of cancer. ECM stiffness and composition changes promote tumor cell proliferation, invasion and metastasis. Matrix metalloproteinases such as MMP2 and MMP9 degrade ECM barriers, facilitating cancer cell dissemination. Targeting ECM regulators is an active area of anticancer therapeutic development.
Vascular aging and stiffness
Sox9 accelerates vascular aging by regulating ECM composition and stiffness. Dysregulated ECM organization in blood vessels leads to increased arterial stiffness, a major risk factor for cardiovascular disease. Understanding the regulators of ECM organization in vascular cells may reveal targets to slow vascular aging.
Developmental and neurological ECM disorders
ECM organization is critical during development, and its regulation affects stress response genes in larval development. In the nervous system, dynamic ECM organization can be visualized using HaloTag-HAPLN1, and disruptions may contribute to neurological disorders. Ciliary machinery regulation of ECM suggests links to ciliopathies.
From regulation of extracellular matrix organization-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene alter ECM composition? | CRISPR knockout in relevant cell type |
| Does a specific point mutation in an ECM regulator affect function? | CRISPR point mutation knock-in |
| Can we visualize dynamic ECM remodeling in live cells? | HaloTag knock-in of ECM protein |
| Does overexpression of an ECM regulator increase stiffness? | CRISPR overexpression or cDNA overexpression |
| Which genes regulate ECM anisotropy? | Knockout screen followed by imaging |
| How does ECM regulation affect stress response genes? | Knockout in C. elegans larval development |
How to Study the regulation of extracellular matrix organization Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell imaging with HaloTag | Dynamic ECM remodeling | Neuronal ECM organization |
| Confocal microscopy | ECM fiber orientation and anisotropy | Cell collision studies |
| Mass spectrometry proteomics | ECM composition and modifications | Global ECM changes |
| RNA-seq | Transcriptional changes in ECM genes | Knockout/overexpression effects |
| Western blot | Specific ECM protein levels | Validation of proteomics |
| Cell migration assay | Functional ECM remodeling | Cancer invasion |
| Mechanical testing | Matrix stiffness | Vascular aging |
| CRISPR knockout | Gene function loss | Causal testing of regulators |
Imaging-based analysis of ECM organization
Live-cell imaging with tagged ECM proteins such as HaloTag-HAPLN1 allows dynamic visualization of ECM organization. Confocal and super-resolution microscopy can assess collagen fiber orientation and anisotropy. These methods are essential for measuring the frequency and extent of ECM remodeling.
Proteomics and biochemical assays
Mass spectrometry-based proteomics can quantify ECM composition changes following genetic perturbation. Western blotting and ELISA can measure specific ECM proteins and modifying enzymes. These approaches help identify regulatory nodes in ECM organization.
Transcriptomics and gene expression profiling
RNA-seq can reveal transcriptional changes in ECM genes and regulators upon knockout or overexpression. This is particularly useful for identifying downstream effectors of transcription factors like Sox9 and TFAP2C.
Functional assays for cell-ECM interaction
Cell adhesion, migration and proliferation assays can measure the functional consequences of altered ECM regulation. Mechanical testing of matrix stiffness provides biophysical readouts. These assays link molecular regulation to cellular phenotypes.
How CRISPR Can Be Used to Study GO:1903053 regulation of extracellular matrix organization
Knockout
CRISPR knockout is used to delete candidate regulators of ECM organization and assess loss-of-function effects on matrix composition, stiffness and anisotropy. For example, knocking out TFAP2C alters ECM anisotropy by changing cell collision dynamics. Knockout of ciliary genes affects ECM organization, linking cilia to matrix regulation.
Point Mutation
CRISPR point mutation can introduce specific amino acid changes to dissect domain functions of ECM regulators. For instance, mutating the catalytic site of MMP2 or MMP9 can separate enzymatic activity from other functions. This approach is valuable for understanding structure-function relationships in ECM regulation.
Knock-in
Knock-in of tags such as HaloTag allows live imaging of ECM proteins. HaloTag-HAPLN1 knock-in mice or cells enable tracking of dynamic ECM organization in neurons. Knock-in can also be used to introduce disease-associated mutations in ECM genes.
Overexpression
CRISPR activation or cDNA overexpression can increase levels of ECM regulators to test gain-of-function effects. Overexpression of Sox9 in vascular cells accelerates ECM stiffness and aging phenotypes. Overexpression of ECM components can also model fibrotic conditions.
How EDITGENE Supports regulation of extracellular matrix organization Research
Researchers studying regulation of extracellular matrix organization-related genes often need to determine whether a candidate gene is causally involved in ECM remodeling, and which domains or mutations drive its function. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models for such studies.
Contact EDITGENE today to design your custom CRISPR model for regulation of extracellular matrix organization research.
Frequently Asked Questions About regulation of extracellular matrix organization
What is GO:1903053?
GO:1903053 is the Gene Ontology term for regulation of extracellular matrix organization, defined as any process that modulates the frequency, rate or extent of extracellular matrix organization.
What genes are involved in regulation of extracellular matrix organization?
Key genes include SOX9, TFAP2C, MMP2, MMP9, COL1A1, FN1 and HAPLN1, among others.
How is ECM organization regulated?
ECM organization is regulated by signaling pathways, transcription factors, ciliary machinery, mechanical forces and cell collisions.
What diseases are linked to ECM regulation?
Cancer, vascular aging, fibrosis and developmental disorders are linked to dysregulated ECM organization.
What methods study regulation of ECM organization?
Imaging, proteomics, RNA-seq, mechanical testing and CRISPR perturbation are commonly used.
How does Sox9 regulate ECM?
Sox9 acts as a transcription factor that alters ECM composition and stiffness, accelerating vascular aging.
What is the role of TFAP2C in ECM?
TFAP2C-dependent regulation of cell collisions determines ECM anisotropy.
Can CRISPR be used to study ECM regulators?
Yes, CRISPR knockout, point mutation, knock-in and overexpression are powerful for causal testing of ECM regulators.
What is HaloTag-HAPLN1 used for?
HaloTag-HAPLN1 enables live imaging of dynamic neuronal ECM organization.
Why is ECM regulation important in cancer?
Dysregulated ECM organization promotes cancer cell proliferation, invasion and metastasis.
Conclusion
GO:1903053, regulation of extracellular matrix organization, is a critical biological process that controls tissue architecture and function. Its dysregulation contributes to cancer, vascular aging and developmental disorders. Advances in CRISPR-based models and imaging technologies are enabling precise dissection of ECM regulatory mechanisms. EDITGENE supports this research with comprehensive CRISPR services to accelerate discoveries in ECM biology.
References
- 1. Karamanos NK et al.. 2021. A guide to the composition and functions of the extracellular matrix.. FEBS J 288(24):6850-6912 PMID: 33605520
- 2. Hynes RO. 2009. The extracellular matrix: not just pretty fibrils.. Science 326(5957):1216-9 PMID: 19965464
- 3. Collins I et al.. 2020. Regulation of the Extracellular Matrix by Ciliary Machinery.. Cells 9(2) PMID: 31979260
- 4. Sterin I et al.. 2024. Dynamic Organization of Neuronal Extracellular Matrix Revealed by HaloTag-HAPLN1.. J Neurosci 44(43) PMID: 39251350
- 5. Rais A et al.. 2023. A review on regulation of cell cycle by extracellular matrix.. Int J Biol Macromol 232:123426 PMID: 36708893
- 6. Faleeva M et al.. 2024. Sox9 Accelerates Vascular Aging by Regulating Extracellular Matrix Composition and Stiffness.. Circ Res 134(3):307-324 PMID: 38179698
- 7. Chandler LM et al.. 2022. Extracellular matrix regulation of stress response genes during larval development in Caenorhabditis elegans.. G3 (Bethesda) 12(11) PMID: 36000892
- 8. Park D et al.. 2020. Extracellular matrix anisotropy is determined by TFAP2C-dependent regulation of cell collisions.. Nat Mater 19(2):227-238 PMID: 31659294
